Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 20Terminated 3Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Breast Neoplasms 3Neoplasms 2Fallopian Tube Neoplasms 2Stomach Neoplasms 1Ovarian Neoplasms 1Microsatellite Instability 1Lymphedema 1Lung Neoplasms 1Gastritis, Atrophic 1Endometrial Neoplasms 1Depression 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Brenner Tumor 1Breast Carcinoma In Situ 1Anxiety Disorders 1

Interventions

Exercise 18Drug Therapy 17pembrolizumab 12Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Dexamethasone 9Paclitaxel 8Standard of Care 7Oxaliplatin 7Nivolumab 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Control Groups 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Educational Status × Clear all
NCT06117592 2024-02-21

CASCADE

The Christie NHS Foundation Trust

Unknown
1,400 enrolled
Tumor-Agnostic

Neoplasms

NCT05242341 2022-03-04

Increase Understanding and Safety of Treatment

National Taiwan University Hospital

Phase NA Unknown
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡